# Lu AF28996 in Participants With Parkinson's Disease (PD)

> **NCT04291859** · PHASE1 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 57 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Lu AF28996

## Key facts

- **NCT ID:** NCT04291859
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-26
- **Primary completion:** 2025-10-14
- **Final completion:** 2026-02-12
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04291859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04291859, "Lu AF28996 in Participants With Parkinson's Disease (PD)". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT04291859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*